Teva Pharma Industries Ltd
Abschluss
Bilanz
Teva Pharma Industries Ltd (TEVA) im Zahlenüberblick: Gewinn- und Verlustrechnung, Bilanz und Cashflow, wahlweise je Jahr oder Quartal. Im jüngsten Berichtszeitraum (2025) lag „Bilanzsumme" bei 40.747 Millionen USD. Zeilen lassen sich per Häkchen als Diagramm vergleichen.
Alle Werte in Millionen USD.
Zeilen ankreuzen und als Diagramm vergleichen (bis zu 4)
| Position | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.241 | 1.188 | 1.436 | 1.714 | 2.856 | 3.460 | 4.627 | 5.916 | 9.632 | 10.387 | 20.471 | 23.412 | 32.904 | 33.810 | 39.052 | 50.142 | 50.609 | 47.508 | 46.420 | 54.258 | 92.890 | 70.615 | 60.683 | 57.470 | 50.640 | 47.666 | 44.011 | 43.479 | 39.326 | 40.747 | |
| 726 | 669 | 776 | 910 | 1.609 | 2.178 | 2.901 | 3.716 | 4.202 | 5.505 | 7.640 | 9.859 | 11.426 | 12.141 | 12.242 | 14.453 | 16.355 | 13.720 | 14.396 | 18.398 | 16.961 | 15.382 | 13.794 | 13.464 | 13.005 | 12.573 | 12.051 | 12.485 | 12.552 | 13.946 | |
| 61 | 51 | 47 | 77 | 421 | 769 | 810 | 1.057 | 784 | 1.276 | 1.332 | 1.488 | 1.854 | 1.995 | 1.248 | 1.096 | 2.879 | 1.038 | 2.226 | 6.946 | 988 | 963 | 1.782 | 1.975 | 2.177 | 2.165 | 2.801 | 3.226 | 3.300 | 3.556 | |
| 69 | 59 | 49 | 94 | 425 | 790 | 1.046 | 1.379 | 1.041 | 2.211 | 2.044 | 2.875 | 1.907 | 2.248 | 1.284 | 1.096 | 2.879 | 1.038 | 2.226 | 6.946 | 988 | 963 | 1.782 | 1.975 | 2.177 | 2.165 | 2.801 | 3.226 | 3.300 | 3.556 | |
| 328 | 308 | 374 | 465 | 681 | 818 | 1.075 | 1.332 | 1.874 | 2.180 | 2.922 | 3.546 | 4.653 | 5.019 | 5.476 | 6.213 | 5.572 | 5.338 | 5.408 | 5.350 | 7.523 | 7.128 | 5.822 | 5.676 | 4.581 | 4.529 | 3.696 | 3.408 | 3.059 | 3.709 | |
| 329 | 303 | 353 | 351 | 503 | 570 | 781 | 1.005 | 1.286 | 1.114 | 1.879 | 2.440 | 3.396 | 3.332 | 3.866 | 5.012 | 5.502 | 5.053 | 4.371 | 3.966 | 4.954 | 4.924 | 4.731 | 4.422 | 4.403 | 3.818 | 3.833 | 4.021 | 3.007 | 3.179 | |
| – | – | – | – | 534 | 554 | 675 | 827 | 1.278 | 1.361 | 2.193 | 2.515 | 3.699 | 3.766 | 4.357 | 5.947 | 6.315 | 6.635 | 6.535 | 6.544 | 7.439 | 7.673 | 6.868 | 6.436 | 6.296 | 5.982 | 6.158 | – | – | – | |
| – | – | – | – | – | – | 560 | 648 | 2.572 | 2.463 | 8.038 | 8.407 | 12.297 | 12.674 | 15.232 | 18.293 | 18.856 | 18.981 | 18.408 | 19.025 | 44.409 | 28.414 | 24.917 | 24.846 | 20.624 | 20.040 | 17.633 | 17.177 | 15.147 | 16.000 | |
| 85 | 82 | 172 | 293 | 613 | 586 | 737 | 927 | 715 | 635 | 1.987 | 1.919 | 4.581 | 4.053 | 5.751 | 10.316 | 7.745 | 6.476 | 5.512 | 7.675 | 21.487 | 17.640 | 14.005 | 11.232 | 8.923 | 7.466 | 6.270 | 5.387 | 4.418 | 3.781 | |
| 706 | 576 | 776 | 972 | 1.703 | 2.077 | 2.793 | 2.620 | 4.232 | 4.337 | 9.294 | 9.652 | 16.544 | 14.551 | 17.050 | 27.799 | 27.742 | 24.872 | 23.065 | 24.331 | 57.897 | 51.870 | 44.889 | 42.407 | 39.579 | 36.422 | 35.413 | 35.353 | 33.606 | 32.833 | |
| 522 | 428 | 538 | 538 | 784 | 738 | 1.524 | 1.695 | 2.204 | 2.260 | 4.071 | 5.371 | 8.481 | 7.602 | 9.894 | 13.847 | 12.888 | 11.965 | 12.289 | 13.005 | 18.519 | 17.921 | 14.322 | 13.674 | 13.164 | 11.027 | 11.469 | 12.247 | 12.796 | 13.456 | |
| 341 | 240 | 325 | 276 | 342 | 207 | 739 | 644 | 560 | 376 | 742 | 1.841 | 2.906 | 1.301 | 1.432 | 4.280 | 3.006 | 1.804 | 1.761 | 1.585 | 3.276 | 3.646 | 2.216 | 2.345 | 3.188 | 1.426 | 2.109 | 1.672 | 1.781 | 1.820 | |
| 181 | 182 | 209 | 114 | 162 | 532 | 786 | 1.051 | 1.644 | 560 | 2.557 | 1.383 | 2.265 | 2.684 | 2.509 | 1.133 | 3.395 | 3.317 | 3.171 | 1.918 | 2.157 | 2.069 | 1.853 | 1.718 | 1.756 | 1.686 | 1.887 | 2.602 | 2.203 | 2.531 | |
| – | – | – | – | 814 | 1.247 | 1.161 | 815 | 1.728 | 1.773 | 4.585 | 3.347 | 5.537 | 4.311 | 4.110 | 10.236 | 11.712 | 10.387 | 8.566 | 8.347 | 32.524 | 28.829 | 26.700 | 24.562 | 22.731 | 21.617 | 19.103 | 18.161 | 16.002 | 14.986 | |
| 534 | 612 | 659 | 742 | 1.151 | 1.381 | 1.829 | 3.289 | 5.389 | 6.042 | 11.142 | 13.724 | 16.300 | 19.222 | 21.947 | 22.195 | 22.768 | 22.565 | 23.313 | 29.769 | 33.337 | 17.359 | 14.707 | 13.972 | 10.026 | 10.278 | 7.804 | 7.506 | 5.373 | 7.910 | |
| 376 | 457 | 506 | 604 | 728 | 970 | 1.346 | 1.960 | 2.171 | 3.082 | 3.398 | 5.041 | 5.288 | 6.662 | 9.325 | 11.284 | 12.346 | 12.535 | 14.436 | 14.851 | 13.607 | -3.803 | -5.958 | -6.956 | -10.946 | -10.529 | -12.975 | -13.534 | -15.173 | -13.762 | |
| 489 | 489 | 488 | 492 | 521 | 546 | 562 | 590 | 688 | 681 | 805 | 830 | 820 | 896 | 921 | 893 | 873 | 850 | 858 | 864 | 961 | 1.016 | 1.021 | 1.091 | 1.095 | 1.107 | 1.110 | 1.119 | 1.131 | 1.173 |
Datenstand: 21. August 2026 · Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q)
Hinweis: reine Faktenanalyse, keine Anlageberatung und keine Aufforderung zum Kauf oder Verkauf. Angaben ohne Gewähr.